Antiangiogenic effect of silicate nanoparticle on retinal neovascularization induced by vascular endothelial growth factor

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 5, 2012, Pages 784-791

  Jo, Dong Hyun ^a   Kim, Jin Hyoung ^a   Yu, Young Suk ^a   Lee, Tae Geol ^b   Kim, Jeong Hun ^a  

^a Seoul National University   (South Korea)

^b Korea Research Institute of Standards and Science   (South Korea)

Author keywords

Oxygen induced retinopathy; Retinal neovascularization; Silicate nanoparticle; Vascular endothelial growth factor receptor

Indexed keywords

ANGIOGENESIS; ANTIANGIOGENIC; FUTURE APPLICATIONS; IN-VITRO; INTRAVITREAL INJECTION; NEOVASCULARIZATION; PRECLINICAL STUDIES; RETINAL DISEASE; RETINAL TISSUE; SILICATE NANOPARTICLES; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VISION LOSS;

DRUG THERAPY; ENDOTHELIAL CELLS; EYE PROTECTION; NANOPARTICLES; OXYGEN; PHOSPHORYLATION; SILICATES; TISSUE; VISION;

OPHTHALMOLOGY;

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NANOPARTICLE; OXYGEN; SILICATE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BLINDNESS; CELL MIGRATION; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN RETINAL MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NEWBORN; NICK END LABELING; NONHUMAN; PHOSPHORYLATION; RETINA NEOVASCULARIZATION; RETINA NERVE CELL; RETINOBLASTOMA; RETINOPATHY;

ANGIOGENESIS INHIBITORS; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; ENDOTHELIAL CELLS; HUMANS; INTRAVITREAL INJECTIONS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; NANOPARTICLES; OXYGEN; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RETINAL NEOVASCULARIZATION; RETINAL NEURONS; SILICATES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 84862685176     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2011.09.003     Document Type: Article

References (27)

1. Folkman J. Angiogenesis. Annu Rev Med 2006, 57:1-18.
2. Gariano R.F., Gardner T.W. Retinal angiogenesis in development and disease. Nature 2005, 438:960-966.
3. Aiello L.P., Avery R.L., Arrigg P.G., Keyt B.A., Jampel H.D., Shah S.T., et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994, 331:1480-1487.
4. Jo D.H., Kim J.H. How to overcome retinal neuropathy: the fight against angiogenesis-related blindness. Arch Pharm Res 2010, 33:1557-1565.
5. Mukherjee P., Bhattacharya R., Wang P., Wang L., Basu S., Nagy J.A., et al. Antiangiogenic properties of gold nanoparticles. Clin Cancer Res 2005, 11:3530-3534.
6. Kalishwaralal K., Sheikpranbabu S., Barathmanikanth S., Haribalaganesh R., Ramkumarpandian S., Gurunathan S. Gold nanoparticles inhibit vascular endothelial growth factor-induced angiogenesis and vascular permeability via Src-dependent pathway in retinal endothelial cells. Angiogenesis 2011, 14:29-45.
7. Gurunathan S., Lee K.J., Kalishwaralal K., Sheikpranbabu S., Vaidyanathan R., Eom S.H. Antiangiogenic properties of silver nanoparticles. Biomaterials 2009, 30:6341-6350.
8. Kim J.H., Kim M.H., Jo D.H., Yu Y.S., Lee T.G. The inhibition of retinal neovascularization by gold nanoparticles via suppression of VEGFR-2 activation. Biomaterials 2011, 32:1865-1871.
9. Kim J.H., Kim K.W., Kim M.H., Yu Y.S. Intravenously administered gold nanoparticles pass through the blood-retinal barrier depending on the particle size, and induce no retinal toxicity. Nanotechnology 2009, 20:505101.
10. Sekhon B.S., Kamboj S.R. Inorganic nanomedicine: Part 2. Nanomedicine 2010, 6:612-618.
11. Couleaud P., Morosini V., Frochot C., Richeter S., Raehm L., Durand J.O. Silica-based nanoparticles for photodynamic therapy applications. Nanoscale 2010, 2:1083-1095.
12. Hartlen K.D., Athanasopoulos A.P., Kitaev V. Facile preparation of highly monodisperse small silica spheres (15 to >200 nm) suitable for colloidal templating and formation of ordered arrays. Langmuir 2008, 24:1714-1720.
13. Song N.W., Park K.M., Lee I.H., Huh H. Uncertainty estimation of nanoparticle size distribution from a finite number of data obtained by microscopic analysis. Metrologia 2009, 46:480-488.
14. Kim J.H., Yu Y.S., Kim D.H., Kim C.J., Kim K.W. Establishment and characterization of a novel, spontaneously immortalized retinoblastoma cell line with adherent growth. Int J Oncol 2007, 31:585-592.
15. Prow T.W., Bhutto I., Kim S.Y., Grebe R., Merges C., McLeod D.S., et al. Ocular nanoparticle toxicity and transfection of the retina and retinal pigment epithelium. Nanomedicine 2008, 4:340-349.
16. Kim J.H., Kim C., Lee B.J., Yu Y.S., Park K.H., Kim K.W. Absence of intravitreal bevacizumab-induced neuronal toxicity in the retina. Neurotoxicology 2008, 29:1131-1135.
17. Smith L.E., Wesolowski E., McLellan A., Kostyk S.K., D'Amato R., Sullivan R., et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994, 35:101-111.
18. Kim J.H., Yu Y.S., Shin J.Y., Lee H.Y., Kim K.W. Deguelin inhibits retinal neovascularization by down-regulation of HIF-1alpha in oxygen-induced retinopathy. J Cell Mol Med 2008, 12:2407-2415.
19. Kim J.H., Yu Y.S., Park K.H., Kang H.J., Lee H.Y., Kim K.W. Antiangiogenic effect of deguelin on choroidal neovascularization. J Pharmacol Exp Ther 2008, 324:643-647.
20. Min J.K., Cho Y.L., Choi J.H., Kim Y., Kim J.H., Yu Y.S., et al. Receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient mice. Blood 2007, 109:1495-1502.
21. Weis S.M., Cheresh D.A. Pathophysiological consequences of VEGF-induced vascular permeability. Nature 2005, 437:497-504.
22. Kim J.H., Lee Y.M., Ahn E.M., Kim K.W., Yu Y.S. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation. J Cereb Blood Flow Metab 2009, 29:1559-1567.
23. Kim J.H., Lee Y.M., Ahn E.M., Kim K.W., Yu Y.S. Decursin inhibits retinal neovascularization via suppression of VEGFR-2 activation. Mol Vis 2009, 15:1868-1875.
24. Jiang B.H., Liu L.Z. PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochim Biophys Acta 2008, 1784:150-158.
25. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L., et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995, 376:62-66.
26. Takahashi T., Yamaguchi S., Chida K., Shibuya M. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J 2001, 20:2768-2778.
27. Kunzmann A., Andersson B., Thurnherr T., Krug H., Scheynius A., Fadeel B. Toxicology of engineered nanomaterials: Focus on biocompatibility, biodistribution and biodegradation. Biochim Biophys Acta 1810, 2011:361-373.